Navigation Links
Cancers in Medical Technology

First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center

... on three patients with non-melanoma skin cancers under the direction of James S. Welsh, M.S., ... FDA cleared for use in the treatment of surface cancers or conditions where radiation therapy is ... is also cleared for use in the treatment of other cancers or conditions where radiation therapy is ...

Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story

... in survival based on race for a number of other cancers -- lung, colon, lymphoma, leukemia, and multiple ... African-American patients with one of these three cancers faced a significantly higher risk of death than ... the metabolism of chemotherapy drugs or that make cancers more resistant or more aggressive," she adds. ...

Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting

... the inability to diagnose patients' primary cancers makes it more difficult for physicians to ... tests, thereby helping to reduce the number of cancers that remain "unknown". The blinded study ... methods often fail to properly diagnose unknown cancers even after extensive work-up that could cost up ...

Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis

... as accurately identifying potentially aggressive cancers while minimizing "false positive" results that ... need better tools to detect significant prostate cancers earlier, to reduce unnecessary biopsies and ... higher in men with pathologically significant cancers than in men with insignificant ones.(2) ...

Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update

... of Clinical Oncology (ASCO) 2009 Genitourinary cancers Symposium. Efficacy results to date showed ... cancer (CRC) at the ASCO 2009 Gastrointestinal cancers Symposium. Results continued to show that ... 2 trials of picoplatin in colorectal and prostate cancers at medical conferences this year; and ...

Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer

... Society of Clinical Oncology (ASCO) Genitourinary cancers Symposium - MALVERN, Pa., Feb. 27 ... Society of Clinical Oncology (ASCO) Genitourinary cancers Symposium in Orlando, FL. AT-101, an oral, ... treatment. One process by which prostate cancers may develop resistance to systemic treatment is ...

Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer

... arise from a number of high incidence cancers as well as HRPC (e.g. breast, lung and thyroid). ... are a serious consequence of certain advanced cancers causing intractable and debilitating pain as well ... in patients with lung, kidney and thyroid cancers - respectively in 30-40%, 20-25% and 60% of ...

New Breast Imaging Technology Targets Hard-to-Detect Cancers

... imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, ... and clinical breast exam. However, some cancers are difficult to detect with mammography and ... excellent tool for locating difficult-to-detect cancers and for screening high-risk women who have ...

Young Women Diagnosed with Early-Stage Breast Cancer More Likely to Die than Older Women

... They looked at all young women with Stage I cancers and compared them with older women with Stage ... women under 40 diagnosed with Stages I and II cancers are 44 percent and 9 percent, respectively, more ... is found in all the cells of the human body. Some cancers make extra copies of this gene, which also is ...

National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon

... cause of cancer death in the U.S. However, most cancers of the lower gastrointestinal (GI) tract can ... that 12-24% of polyps and a significant number of cancers can be missed during colonoscopy. [1], [2], [3] ... for the improved detection and prevention of cancers of the gastrointestinal (GI) tract. The ...

AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108

... is part of a Phase 2 program in gynaecological cancers for which patient enrolment began in ... Phase 1 study in various gynaecological cancers were presented at the American Society of ... with LHRH-receptor positive gynaecological cancers were recruited. AEZS-108 was administered ...

ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options

... (polyps most likely to become cancerous) or cancers 10 mm or larger that were detected by colonoscopy ... The sensitivity for the detection of adenomas or cancers greater than or equal to 5 mm, 6 mm, 7 mm, 8 ... detection by CT colonography of large adenomas or cancers 10 mm or larger. The radiologists making ...

Prescription Sleeping Pill Use Tied to Cancer

... Kripke found eight non-melanoma skin cancers and four tumors of uncertain malignancy in the ... to have developed kidney, thyroid and testicular cancers and suffer chromosome damage, which is a sign of ... studies of several drugs and the number of cancers observed during controlled hypnotics trials ...

Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer

... potential treatment for specific types of brain cancers have activity against human pancreatic cancers in a mouse model. Dr. John S. Kovach, President ... activity against several types of human cancers in the test tube and against ...

Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer

... than the digital rectal exam. However, prostate cancers that are found with a PSA test take years to ... incontinence and impotence. These slow-growing cancers may never have affected a patient's health ... detected by screening. "Because many prostate cancers grow slowly, early detection may not benefit a ...

Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO

... preclinical models. Five patients with various cancers have experienced stable disease for at least ... development of treatments for the many different cancers that involve the PI3K pathway," said Dr. ... cell growth. PI3K is activated in human cancers by elevated receptor tyrosine kinase activity, by ...

Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds

... (n=14) and the non-FIT cohort (n=14), colorectal cancers in the FIT cohort were detected an average ... detected 86 percent (12 of 14) of colorectal cancers and 63 percent (60 of 96) of advanced adenomas ... Currently, less than 40 percent of colorectal cancers are found early.(3) The new data presented today ...

Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer

... to routine mammography revealed 28 percent more cancers than mammography alone. However, the additional ... screening. Mammography alone revealed 20 cancers (50 percent of all cancers detected) for a cancer ... mammography plus screening ultrasound revealed 31 cancers (78 percent of all cancers detected) for a cancer ...

Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies

... Society of Clinical Oncology Gastrointestinal cancers Symposium to be Used in Selecting Final Genes for ... Society of Clinical Oncology's Gastrointestinal cancers Symposium, in Orlando, Florida. "These results ... chemotherapy. The first report evaluated colon cancers from patients treated with surgery alone, ...

Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium

... in Gastroesophageal and Colorectal cancers - NUTLEY, N.J., Jan. 24 /PRNewswire/ -- Roche ... for presentation at the 2008 Gastrointestinal cancers Symposium in Orlando, Fla., from Jan. 25 to 27. ... to 5-FU in gastroesophageal and colorectal cancers and support further clinical testing to examine ...

Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection

... States annually than breast, prostate and colon cancers combined.(1) Eighty million chest X-rays are ... However, without chest X-ray CAD, many lung cancers may not be found or are overlooked when lung ... on the market.(3) "Unfortunately, most lung cancers are diagnosed too late for treatment to ...

BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data

... are associated with a high rate of relapse. Such cancers are particularly prevalent in premenopausal ... gene expression in 169 infiltrating ductal breast cancers through the use of the Gene Logic Inc. (Nasdaq: ... and Phase 2 trials of BSI-201 in other major cancers that overexpress PARP over the next several ...

Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers

... in primary liver (HCC) cancers, squamous cell cancers (including lung) and melanoma. All three patients ... to the effectiveness of JX-594 against liver cancers and squamous cell cancers including lung cancer," said Herbert M. Pinedo, ....

DAHANCA Initiates Head and Neck Cancer Study With Genmab's HuMax-EGFr

... survival and acute and late side effects. About cancers of the head and neck Head and neck cancers may affect the mouth, nasal cavities, ... and lymphoma. Head and neck cancers account for 3 % ...

International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit

... Cancer Institute's National Center for Vermiculite and Asbestos-Related cancers (NCVAC) have discovered a probable reason for the unrelenting chest pain ... National Center for Vermiculite and Asbestos-Related cancers (NCVAC at Karmanos) In response to the United States ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... Malignancies reported through week 104 consisted of two basal cell skin cancers (one patient on SIMPONI 100 mg, one placebo patient). No deaths occurred. ... or other TNF blockers, your risk for developing lymphoma or other cancers may increase. You should tell your doctor if you have had or develop ...

Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual

... percutaneous hepatic perfusion (PHP(TM)) system for the treatment of cancers of the liver, announced today that it has achieved the seventy-five ... in Phase III and Phase II clinical studies for the treatment of liver cancers using high doses of melphalan. The Company's intellectual property ...

Heaviest Smokers Face Greatest Risk of Death After Lung Cancer Diagnosis

... who smoked two packs a day had a 58 percent higher risk of their lung cancers returning or spreading compared with nonsmoking patients. Smoking ... who smoked more than 61 packs a year had the greatest risk of their cancers recurring, and their survival times were shortest. They were 41 percent ...

Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients

... to expand this study and evaluate additional patients with a variety of cancers as well as specifically those with colorectal and ovarian cancers. These ... of cancer. ENMD-2076 is currently in Phase 1 studies in advanced cancers and multiple myeloma. The Company's other therapeutic candidates include ...

Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology

... more deaths from lung cancer alone than from breast, colon, and prostate cancers combined - and it's extremely difficult to treat," said Professor Roy ... half of patients can survive for five years or more. However, few lung cancers are found at this early stage and it is normally diagnosed at the advanced ...

Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer

... in the CXC chemokine receptor family that is expressed on a variety of cancers including leukemias, lymphomas, breast, lung, colon, pancreatic, and ... of the cell plasma membrane, that is expressed on most small cell lung cancers (SCLC). In in vitro preclinical studies, a fully human, non-fucosylated ...

Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference

... before a novel experimental antitumor agent -- which works best in breast cancers expressing the estrogen receptor (ER) -- estrogen receptors were ... agents and the drug combination," Dr. Burger said. "Triple-negative breast cancers might respond against that drug (AFP464)." Triple-negative breast ...

Genetic Source of Rare Childhood Cancer Found; Gene is Implicated in Other Cancers

... disease or certain other childhood cancers. In contrast, most pediatric cancers occur sporadically, without any familial patterns. This led scientists and doctors to suspect that the cancers were caused by an inherited genetic abnormality. To uncover the role of ...

Cylene to Present Advances in its Oral Inhibitor of CK2 at AACR Annual Meeting

... of protein kinase CK2. CK2 overexpression is well documented in many cancers and represents a previously unexploited molecular target. CX-4945 is a ... in cancer cells. CX-4945, which has broad therapeutic potential in common cancers as well as in niche indications, has advanced rapidly into Phase I ...

EAU Position Statement on Screening for Prostate Cancer

... well as the adverse effects of overdiagnosis and overtreatment of prostate cancers which could be quantified for the first time in the setting of a ... due to a lack of specificity and lack of selectivity for aggressive cancers which require treatment. The development of novel diagnostic and ...

Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap

... of HPV testing significantly reduces the numbers of advanced cervical cancers and deaths, compared with Pap (cytology) testing or visual inspection with ... with a significant reduction in the numbers of advanced cervical cancers and deaths from cervical cancer," QIAGEN's hc2 HPV testing platform "was ...

Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows

... medications. The Tufts researchers found 2,334 cases of cancers reported in the total population studied. Cancer rates were analyzed ... continued Dr. Karas. This research, which explored three times more cancers than analyzed by Sir Richard Peto from the SEAS, SHARP and IMPROVE-IT ...

SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists

... who have received specialized training, and the link between gynecologic cancers and breast cancers is clear. We are extremely grateful to ACOG for recognizing this important ...

Dr. James F. Pingpank to Present at Leading Regional Therapies Conference

... Percutaneous Hepatic Perfusion ("PHP(TM)") System for the treatment of cancers of the liver, announced today that Dr. James F. Pingpank will present at ... in Phase III and Phase II clinical studies for the treatment of liver cancers using high doses of melphalan. The Company's intellectual property ...

Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass

... Cancer Ovarian cancer is the leading cause of death from gynecologic cancers in the U.S. and the fifth-leading cause of cancer death in women. It accounts for 31% of cancers of the female genital organs. There are an estimated 22,000 new cases ...
Other Contents
(Date:7/10/2014)... 30, 2014  Aware, Inc. (NASDAQ: AWRE ... previously announced on June 26, 2014 that its Board ... $1.75 per share, or approximately $40 million in total.  ... 2014 and a payment date of July 24, 2014.  ... had set an ex-dividend date for this special cash ...
(Date:7/10/2014)... July 2, 2014  Unisys Corporation,s (NYSE: UIS ... Nederland N.V., today announced that it has been selected by ... manage a new Basic Provision Biometrics solution for penitentiaries across ... won the contract with a solution based on its open ... term of the contract is up to seven years, with ...
(Date:7/10/2014)... , July 2, 2014 NXT-ID, Inc., (OTCQB: NXTD) a biometric ... CEO Mr. Gino Pereira was interviewed on July ... Tampa Florida . Mr. Pereira discusses the ... Cedric Harris and how the Wocket™ aims to replace ... Cedric Harris tells Gino he has ...
Breaking Biology News(10 mins):NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 2Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 4
(Date:7/13/2014)... Celebrity fitness trainer and former World Super ... with Aqua Health Labs for their flagship product PhytOriginal, ... The collaboration was recently announced live on ESPN Radio. ... actor, model, and a two time World Super Middleweight ... has prepared stars including Demi Moore, Hilary Swank and ...
(Date:7/13/2014)... 2014 According to The Peripheral Neuropathy ... comprehensive program that teaches people how to deal with ... without medications. This program also provides people with safe ... neuropathy , including numbness, prickling, burning, and intense stabbing ... this home treatment program can help people eliminate some ...
(Date:7/12/2014)... Fadhits.com, a well-known wedding dress manufacturer and retailer, has added ... to its product line. In addition, the company has launched ... bring more benefits for its loyal fans. All its ... to 72% off. , As a leader in the garment ... is a good place for ladies who want to purchase ...
(Date:7/12/2014)... FL (PRWEB) July 12, 2014 Fresh off ... and Colombia will meet on September 5th at Sun ... the world to see some of the brightest stars in ... soccer fans in Miami will be treated to some of ... Brazil is currently ranked as the third best team in ...
(Date:7/12/2014)... The "North American Interventional ... by Angioplasty Balloon (Plain/Old, Cutting), Stent ... Filter (Retrievable), Endovascular Stent Graft - ... the major market drivers, restraints, and ... , Browse 108 market data tables ...
Breaking Medicine News(10 mins):Health News:Celebrity Fitness Expert Supports Revolutionary New Health Supplement 2Health News:The Peripheral Neuropathy Program Review Exposes Randall Labrum's Peripheral Neuropathy Treatment Program – Vkool.com 2Health News:The Peripheral Neuropathy Program Review Exposes Randall Labrum's Peripheral Neuropathy Treatment Program – Vkool.com 3Health News:New Collection of Long Graduation Dresses Revealed by Fadhits.com 2Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 2Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5
Other TagsOther Tags